Metropolitan Business Solutions Is Here To Help You With:
Insurance Follow-up: Our staff of professionals optimize your insurance follow-up process and obtain timely results. A true extension of your business office.
Medical Debt Collection: MBS gets results through proven, respectful medical debt collection methods while minimizing patient complaints.
Cash Acceleration & Receivable Management Services: When you outsource receivables management to MBS, our staff becomes an extension of your own business office at a fraction of the cost.
Revenue Cycle Consulting: Our revenue cycle experts can help you optimize cash flow and efficiency while reducing your expenses.
Products and services: Medical financial management services from MBS help your organization run more smoothly, so you can collect revenue faster.
We have cultivated the expertise to bill and create claims that positively affect your bottom line with MBS’ knowledge of multi-specialized billing including;
CURRENTLY BEING UPDATED
CURRENTLY BEING UPDATED
DefinitionSmart makes use of the data bank a laboratory produces to create claims, while BioData Logistics Enterprise Laboratory Platform manages all this data to adhere to compliance and insurance specific regulations, making it an all-in-one service option for free standing laboratories and POLS
MBS guarantees an increase in collections with DefintionSmart by featuring:
DefinitionSmart in collaboration with BioData Logistics encompasses all of the traditional LIMS and ELN concepts and extends them even further by adding complementary capabilities and technologies with complete and seamless integration.
LIST OF LABORATORY TESTING MBS DOES
Comprised of LIMS (Laboratory Information Management System) and ELN (Electronic Laboratory Notebook) functioning as an integrated single solution, it offers the industry’s broadest range of user-configurable functionality and is based on open standards. This provides the best solution to current requirements and also enables the system to be readily adapted as your business needs change. Our commitment to open standards also means that the Definition Smart solution will be compatible with your existing computing environment and that you can be confident it will adapt to the future. Definition Smart customers easily upgrade to new release versions and implement new computing technology without reconfiguration. Our unique software enhancement program provides continuous added value in the form of new product features and functional modules. Biodata Logistics Enterprise Laboratory Platform encompasses all of the traditional LIMS and ELN concepts and extends them even further by adding complementary capabilities and technologies. Most importantly, it does so with complete and seamless integration.
MBS by commissioning BDL, Inc. has developed medical billing software specifically for laboratories. We guarantee an increase in collections when you install our Laboratory Billing Software solution. With more than 34 years experience developing Laboratory Billing Software systems, BDL has developed its Laboratory Billing Software with the following features: We have a powerful HL7 bi-directional interface that seamlessly sends and receives billing information between your LIMS and our Definition Smart linked Laboratory Billing Software. Transparent interface to Laboratory Information System developed in conjunction with a large LIMS vendor. Both systems working together help keep all records updated and correct within our Laboratory Billing Software.
What does it resolve?
Pharmacogenetic (or PGx for short) testing is a type of genetic test that assesses a patient’s risk of an adverse response or likelihood to respond to a given drug, informing drug selection and dosing. As a pillar of the personalized medicine movement, PGx testing is anticipated to be important across all medical specialties, but particularly in primary care, where the majority of all drug prescriptions are written.
Like PGx, cancer-genetic testing (or CGx for short) is also a type of genetic test. However, rather than assess risks with prescribed drugs, CGx tests for and estimates a patients likelihood of developing cancer within their lifetime. This is done by looking at specific genes, chromosomes, and even proteins.
MBS is currently navigating these fields with great results and hope to offer billing services for these procedures soon!
